STAT

Opinion: Today’s insulin isn’t what Banting and Best developed. It’s far, far better

Headlines like "The U.S. Insulin Crisis — Rationing a Lifesaving Medication Discovered in the 1920s" imply that insulin hasn't changed much. That's wrong.

Here’s the kind of headline that has been appearing a lot recently, but it is more jarring — and worrisome — when it appears in the New England Journal of Medicine: “The U.S. Insulin Crisis — Rationing a Lifesaving Medication Discovered in the 1920s.”

The sentiment that Americans are now paying dearly for the insulin pioneered nearly a century ago have helped fuel attacks against the biopharmaceutical industry, enabling politicians like Sen. Bernie Sanders (I-Vt.) to depict companies to buy this medication.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Amylyx Pulling Its ALS Drug, GLP-1 Drugs For Parkinson’s, And More
Amylyx Pharmaceuticals will take its ALS drug Relyvrio off the market in the U.S. and Canada, ending a multi-year saga for patients with the rare neurodegenerative disease.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.

Related Books & Audiobooks